According to DBV Technologies's latest financial reports and stock price the company's current Operating Margin is -22,116.30%. At the end of 2015 the company had an Operating Margin of -22,116.34%.
Year | Operating Margin | Change |
---|---|---|
2015 | -22,116.34% | 94.12% |
2014 | -11,393.05% | 7.28% |
2013 | -10,619.59% | 42.3% |
2012 | -7,462.72% | 29.91% |
2011 | -5,744.62% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Ionis Pharmaceuticals
IONS | -43.95% | -99.80% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | -79.07% | -99.64% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -108.63% | -99.51% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.